Prostate cancer active surveillance in solid organ transplant: a matched study and literature review
BJU International · 2025
DOI: 10.1111/bju.16777 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BJU International, 2025. Verfasst von Mark N Alshak und 8 weiteren Autor:innen. Beteiligte Einrichtung: The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Organ Transplantation, Watchful Waiting. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objectives
To evaluate outcomes of prostate cancer (PCa) active surveillance (AS) in patients with versus without solid organ transplant (SOT), as the safety of PCa AS in patients with SOT remains understudied. We also performed a literature review to identify all studies describing PCa AS in patients with SOT. Patients and Methods A retrospective study was conducted for patients with SOT (kidney, liver, heart, lung) with a diagnosis of PCa enrolled into AS either before or after SOT. Using prospectively collected information, they were matched with non‐SOT AS patients at PCa diagnosis by age, race, prostate‐specific antigen, and Gleason Grade Group (GGG). A scoping review was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines.
Results
A total of 32 SOT AS patients were matched with 99 non‐SOT AS patients. After matching, there was no significant difference in baseline demographics. 34% were enrolled into AS before SOT. The median time on AS for patients with and without SOT was 4.7 and 4.98 years, respectively ( P = 0.87). In all, 53% of patients with SOT and 54.5% those without SOT were still on AS ( P = 0.99). In all, 28.1% of patients with and 39.4% without SOT progressed to definitive treatment ( P = 0.30), and there were no differences in rates of grade re‐classification or GGG at definitive treatment. No systemic disease progression or PCa‐specific deaths occurred. In the literature, we identified and reviewed 11 studies and found 99 patients enrolled into AS either before ( n = 33) or after ( n = 66) SOT. We did not identify a safety signal.
Conclusion
We present the largest series of patients with PCa on AS with SOT. In patients with SOT and PCa on AS, a surveillance strategy appears safe and has similar outcomes as those without SOT on AS. Our review found a paucity of AS data in the SOT setting suggesting that further research is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.
- Johns Hopkins School of Medicine, Baltimore, MD, USA.
- Welch Medical Library, Johns Hopkins School of Medicine, Baltimore, MD, USA.
ORCID-Profile: Mark N Alshak, Joseph G Cheaib, Carlos A Rivera Lopez, Christian P Pavlovich
Zitieren
APA
Alshak, M. N., Higgins, M. I., Grutman, A. J., Campbell, J., Cheaib, J. G., Rivera Lopez, C. A., Spann, M., Jing, Y., & Pavlovich, C. P. (2025). Prostate cancer active surveillance in solid organ transplant: a matched study and literature review. BJU International. https://doi.org/10.1111/bju.16777
Vancouver
Alshak MN, Higgins MI, Grutman AJ, Campbell J, Cheaib JG, Rivera Lopez CA, et al. Prostate cancer active surveillance in solid organ transplant: a matched study and literature review. BJU International. 2025. doi:10.1111/bju.16777
BibTeX
@article{Alshak2025,
author = {Alshak, Mark N and Higgins, Michelle I and Grutman, Aurora J and Campbell, Jack and Cheaib, Joseph G and Rivera Lopez, Carlos A and Spann, Marcus and Jing, Yuezhou and Pavlovich, Christian P},
title = {Prostate cancer active surveillance in solid organ transplant: a matched study and literature review},
journal = {BJU International},
year = {2025},
doi = {10.1111/bju.16777}
}
EUVIMED